The present invention relates, broadly speaking, to the use of certain ingenol derivatives as reactivators of latent HIV in viral reservoirs. In another aspect, the present invention relates to a combination comprising said ingenol derivatives and antiretroviral agents that are substantially active in terms of actively replicating virus.